#Hepatology Archives - Page 2 of 4

Case Study丨Dr. Jia Shang: Diagnosis and Treatment of Invasive Fungal Infection in Severe Liver Disease Patients

By Mourabit Halima 2024.11.18

Editor's Note: Invasive fungal infection (IFI) refers to a fungal infection that invades the deep tissues and organs of the human body, causing pathological changes such as tissue damage, organ…

$Dr. Ying Han: Early Diagnosis and Intervention Strategies for Refractory Primary Biliary Cholangitis$

Dr. Ying Han: Early Diagnosis and Intervention Strategies for Refractory Primary Biliary Cholangitis

By Peter W. PENG 2024.11.11

Editor’s Note: With shifts in the global landscape of liver diseases, the incidence of primary biliary cholangitis (PBC) has been rising annually. In China, PBC’s prevalence has reached the highest…

Call for Papers by November 24丨Beijing APASL 2025 Annual Meeting, Inviting Liver Disease Research Experts to Participate

By Peng Longmei 2024.11.04

The highly anticipated 34th Annual Meeting of the Asia-Pacific Association for the Study of the Liver (APASL 2025) will be held in Beijing from March 26 to 30, 2025. This…

Metabolic-Related Diseases in Autoimmune Hepatitis Patients Promote Liver Fibrosis

By Peter W. PENG 2024.10.21

Introduction: Autoimmune hepatitis (AIH) is a chronic liver disease that affects both men and women, with about 30% of AIH cases occurring in individuals over 60 years old. Metabolic syndrome,…

Hepatology | Association Between Metabolic-Associated Fatty Liver Disease and Subclinical Hypothyroidism in Adolescents

By Lisa Cui 2024.10.17

Editor's Note: A recent study led by Dr. Vidhu V. Thaker from Columbia University Medical Center has revealed a significant association between subclinical hypothyroidism and metabolic-associated steatotic liver disease (MASLD)…

Dr. Lai Wei: Interpretation of Key Points from the 2024 Edition of the Chinese Guidelines for the Prevention and Treatment of Metabolic (Non-Alcoholic

By Lisa Cui 2024.10.15

Editor's note: Liver diseases, primarily viral hepatitis, metabolic-associated fatty liver disease (MAFLD), and alcoholic liver disease, affect approximately 400 million people in China. With the increasing pace of life, unhealthy…

Impact of Gut Microbiota on Patients with Decompensated Cirrhosis

By Lisa Cui 2024.10.14

Editor’s note: The human gastrointestinal tract hosts trillions of microbes, including bacteria, fungi, and viruses, which play essential roles in physiological functions and disease mechanisms. Extensive research has demonstrated that…

JOH丨Optimizing Algorithms to Narrow the Gray Zone in Diagnosing Clinically Significant Portal Hypertension

By Peter W. PENG 2024.10.12

Editor’s note: Portal hypertension (PHT) in cirrhosis is a leading cause of complications in patients with compensated chronic liver disease (cACLD). Clinically significant portal hypertension (CSPH) is closely linked to…

2024 CACA丨 How to Balance Hepatic Adjuvant Therapy? Dr. Minshan Chen Shares Advances and Strategies in Liver Cancer Adjuvant Treatment

By Peng Longmei 2024.10.09

Hepatocellular carcinoma (HCC), often called the "king of cancers," not only has a low survival rate in advanced stages but also carries a high risk of postoperative recurrence, with a…

Hepatology丨MELD-Na Score Predicts Long-Term Clinical Outcomes After TIPS Surgery

By Lisa Cui 2024.09.27

Editor's Note: The Advancing Liver Therapeutic Approaches (ALTA) research group is an international organization dedicated to advancing new methods of liver disease treatment. Its members are from leading medical institutions…